Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factor.

Dose intensity may be an important determinant of the outcome in cancer chemotherapy, but is often limited by cumulative haematological toxicity. The availability of haematopoietic growth factors such as granulocyte colony-stimulating factor (G-CSF) and of peripheral blood progenitor cell (PBPC) tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Leyvraz, S., Ketterer, N., Perey, L., Bauer, J., Vuichard, P., Grob, J. P., Schneider, P., von Fliedner, V., Lejeune, F., Bachmann, F.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034125/
https://www.ncbi.nlm.nih.gov/pubmed/7541235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034125/
https://www.ncbi.nlm.nih.gov/pubmed/7541235

Ejemplares similares